Previous 10 | Next 10 |
LONDON, UK / ACCESSWIRE / January 9, 2020 / We are initiating coverage of Silence Therapeutics (SLN), a developer of siRNA drugs for diseases that can be genetically targeted. Silence has a proprietary platform for developing siRNA therapeutics, the strength of which was highlighted by precl...
Jadestone Energy Announces Award of Damages in Respect of Philippines Arbitration SINGAPORE / ACCESSWIRE / January 9, 2020 / Jadestone Energy Inc. (AIM:JSE)(TSXV:JSE) ("Jadestone" or the "Company"), an independent oil and gas production company focused on the Asia Pacific region, announce...
ANGLE plc ("the Company") Notification of Interim Results and Webcast GUILDFORD, SURREY / ACCESSWIRE / January 8, 2020 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 31 October 2019 on Thur...
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- RhythmOne LLC, a Tremor International company, today launched a new set of self-serve tools for publishers to activate programmatic deals across connected TV (CTV), video and banner inventory via deal IDs — providing enhanced reporting ...
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection Oxford, UK, and Cambridge, MA, US, 7 January 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUM...
DIDCOT, UK / ACCESSWIRE / January 7, 2020 / Altus Strategies Plc (AIM:ALS & TSX-V:ALTS), the Africa focused project and royalty generator, announces that it has issued 2,000,000 Ordinary Shares (" Consideration Shares ") to AGMEX S.á.r.l. (" AGMEX "), a company incorporated in the R...
LONDON and VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Mkango Resources Ltd. (AIM/TSX-V: MKA) (the "Company" or "Mkango") is pleased to announce the appointment of Mr Tim Slater as Interim Chief Financial Officer (“CFO”) of the Company. The Board of Direc...
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the appointment of David Moskowitz to the newly created position of Vice President, Ca...
For immediate release 6 January 2020 Serabi Gold plc (“Serabi” or the “Company”) Step out drilling at Sao Chico significantly extends resource beyond current mine limits Ser...
ST HELIER, Jersey, Jan. 03, 2020 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) today announces that the Board of Directors has declared an increased quarterly dividend of seven-and-a- half United States cents (US$0.075) on ea...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...